// App-Quantinova.ai

1514 : Phenotype Differences in HLA-B27 Positive Versus Negative Patients with Ankylosing Spondylitis in a Population That Show Relatively Weaker Association with HLA-B27

Researchers

Presenter

  • Handan Yarkan

Principal Investigators

  • Zhixiu Li

  • Gokce Kenar

  • Sedat Capar

  • Fernur apa

  • Rudi Steffensen

  • Servet Akar

  • Dilek Solmaz

  • Pinar Cetin

  • Berrin Zengin

  • Erika de Guzman

  • Katie Cremin

  • Gerek Can

  • Zeynep Yce

  • Ismail Sari

  • Fatos Onen

  • Matt Brown

  • Nurullah Akkoc

Medical Centers

  • Division of Pediatric Endocrinology, Dokuzeylul University, Faculty of Medicine, Izmir, Turkey

  • Translational Genomics Group, Institute of Health and Biomedical Innovation, Queensland University of Technology, Translational Research Institute, Brisbane, Australia, Brisbane, Australia

  • Division of Pediatric Endocrinology, Dokuzeylul University, Faculty of Medicine, Izmir, Turkey

  • Dokuz Eylul University, School of medicine, Izmir, Turkey

  • Department of Molecular Medicine, Dokuz Eylül University Health Sciences Institute, IZMIR, Turkey

  • Department of Oncology, Aalborg University Hospital, Aalborg, Denmark

  • Rheumatology, Izmir Katip Celebi University School of Medicine, Izmir, Turkey

  • Rheumatology, Izmir Katip Celebi University School of Medicine, Izmir, Turkey

  • Division of Pediatric Endocrinology, Dokuzeylul University, Faculty of Medicine, Izmir, Turkey

  • Translational Genomics Group, Institute of Health and Biomedical Innovation, Queensland University of Technology, Translational Research Institute, Brisbane, Australia, Brisbane, Australia

  • TURKBIO, İzmir, Turkey, Izmir, Turkey

  • Toronto General Hospital, University of Toronto, Toronto, ON, Canada

  • TURKBIO, İzmir, Turkey, Izmir, Turkey

  • Rheumatology, Private Practice, Rheumatology, İzmir, Turkey

Locations

  • Turkey

  • Australia

  • Denmark

  • Austria

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • Major Histocompatibility Complex, Class I, B

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved